Fibreoptic bronchoscopy in the diagnosis of pulmonary disease in the immunocompromised host in northern Alberta

To determine the diagnostic utility of bronchoscopy in a population of immunocompromised hosts in northern Alberta. Results from bronchoscopy in 86 immunocompromised patients who underwent a total of 101 procedures were retrospectively reviewed. The overall diagnostic yield was 57% with the highest...

Full description

Saved in:
Bibliographic Details
Published inCanadian journal of infectious diseases Vol. 6; no. 6; pp. 286 - 290
Main Authors Crocket, J A, Chaput, M R, Lien, D C
Format Journal Article
LanguageEnglish
Published Canada Pulsus Group Inc 1995
Wiley
Subjects
Original
Bronchoscopy
Pneumonia
Bronchoalveolar lavage
Immunocompromised host
Online AccessGet full text

Cover

More Information
Summary:To determine the diagnostic utility of bronchoscopy in a population of immunocompromised hosts in northern Alberta. Results from bronchoscopy in 86 immunocompromised patients who underwent a total of 101 procedures were retrospectively reviewed. The overall diagnostic yield was 57% with the highest yield in patients on immunosuppressive drug therapy (80%) and the lowest yield in the group of bone marrow transplant patients (27%). Bronchoscopy is a valuable tool for the evaluation of pulmonary disease in the immunocompromised host. Overall diagnostic yield of 57% is comparable with that reported in the literature.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1180-2332
1712-9532
1918-1493
DOI:10.1155/1995/174578